General Biological Corporation operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares General Biological with three other
companies in this sector in TAIWAN :
Genovate Biotechnology Co., Limited
sales of 472.72 million Taiwanese Dollars [US$17.09 million]
of which 94%
was Medicine Manufacturing),
UBI Pharma Inc
(477.56 million Taiwanese Dollars [US$17.26 million]
of which 75%
was Contract Medicine Manufacturing), and
TSH Biopharm Corp Limited
(447.86 million Taiwanese Dollars [US$16.19 million]
of which 95%
General Biological reported sales of 475.87 million Taiwanese Dollars (US$17.20 million)
December of 2020.
increase of 98.6%
versus 2019, when the company's sales were 239.65 million Taiwanese Dollars .